Wilbraham, MA, United States of America

Alexis Hiram Ramos

This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignees: Flagship Pioneering Innovations Vi, LLC, Generate Biomedicines, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexis Hiram Ramos. Retrieved from https://idiyas.com/inventor/alexis-hiram-ramos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • Wilbraham, MA (US) (2024)
  • Cambridge, MA (US) (2024)

Company Filing History:


Years Active: 2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Alexis Hiram Ramos: Pioneering Patents in Biomedical Research

Introduction

Alexis Hiram Ramos, an inventive force based in Wilbraham, MA, has made significant contributions to the field of biomedical research with a total of three patents to his name. His work primarily focuses on developing therapeutic solutions targeting various diseases and conditions, demonstrating his commitment to enhancing health outcomes through innovative science.

Latest Patents

Ramos's latest patents showcase groundbreaking discoveries in the realm of antigen binding molecules. One of his notable inventions targets thymic stromal lymphopoietin (TSLP). This patent presents several polypeptides, including antibodies that specifically bind to TSLP, which is essential for understanding and treating associated diseases. The technology also encompasses fusion proteins, polynucleotides encoding the polypeptides, and methods for effective treatment of TSLP-related conditions.

Another key patent developed by Ramos focuses on antigen binding molecules that target SARS-CoV-2. This invention includes polypeptides designed to bind specifically to S2 domains of betacoronavirus Spike glycoproteins, such as those found in SARS-CoV-2. The patent describes various embodiments that include fusion proteins, polynucleotides, vectors, and host cells aimed at providing therapeutic interventions, particularly against viral infections like COVID-19.

Career Highlights

Throughout his career, Alexis Hiram Ramos has collaborated with esteemed companies in the field of biomedicine. Notably, he has worked with Flagship Pioneering Innovations and Generate Biomedicines, Inc., where his innovative work has gained recognition and propelled advancements in therapeutic development.

Collaborations

Ramos has notable collaborations with fellow researchers, including Gevorg Grigoryan and John Ingraham. Their collective efforts in scientific research have contributed to the successful development of innovative solutions in their respective areas of expertise.

Conclusion

In conclusion, Alexis Hiram Ramos stands out as a prominent inventor, driving advancements in biomedicine through his innovative patents. His work not only expands the scope of therapeutic options available for various diseases but also reinforces the importance of collaboration within the scientific community in tackling global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…